当前位置: X-MOL 学术Technology Innovation Management Review › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Blockchain-enabled Clinical Study Consent Management
Technology Innovation Management Review ( IF 1.6 ) Pub Date : 2020-02-29 , DOI: 10.22215/timreview/1325
Hans H. Jung , Franz M.J. Pfister

1.1 Relevance of the Subject Conducting clinical studies includes an obligation to publish results to participants, sponsors, colleagues, and the public (Antes, 2009). ClinicalTrials.gov lists over 304,000 studies with locations in 208 countries (ClinicalTrials, 2019). The German Register of Clinical Trials (Deutsches Register für Klinische Studien, [DRKS]) is the primary registry for Germany. The aim of this registry is as a central contact point to provide the public with a complete and up-to-date overview of clinical trials conducted in Germany. The University Hospital of Freiburg started implementing DRKS as part of a BMBF project in 2017. Since July 1st of that year, the German Institute has continued it permanently for Medical Documentation and Information (Deutsches Institut für Dokumentation und Information, [DIMDI], 2019).

中文翻译:

基于区块链的临床研究同意管理

1.1 受试者的相关性 进行临床研究包括向参与者、申办者、同事和公众公布结果的义务(Antes,2009)。ClinicalTrials.gov 列出了 304,000 多项研究,地点分布在 208 个国家/地区(ClinicalTrials,2019 年)。德国临床试验注册中心 (Deutsches Register für Klinische Studien, [DRKS]) 是德国的主要注册中心。该注册中心的目的是作为一个中央联络点,为公众提供在德国进行的临床试验的完整和最新概述。弗莱堡大学医院于 2017 年开始实施 DRKS 作为 BMBF 项目的一部分。 自当年 7 月 1 日起,德国研究所一直在继续实施医学文献和信息(Deutsches Institut für Dokumentation und Information,[DIMDI],2019) .
更新日期:2020-02-29
down
wechat
bug